論文

査読有り 筆頭著者 責任著者 国際誌
2022年10月28日

The N6-methyladenosine methyltransferase METTL16 enables erythropoiesis through safeguarding genome integrity.

Nature communications
  • Masanori Yoshinaga
  • Kyuho Han
  • David W Morgens
  • Takuro Horii
  • Ryosuke Kobayashi
  • Tatsuaki Tsuruyama
  • Fabian Hia
  • Shota Yasukura
  • Asako Kajiya
  • Ting Cai
  • Pedro H C Cruz
  • Alexis Vandenbon
  • Yutaka Suzuki
  • Yukio Kawahara
  • Izuho Hatada
  • Michael C Bassik
  • Osamu Takeuchi
  • 全て表示

13
1
開始ページ
6435
終了ページ
6435
記述言語
英語
掲載種別
研究論文(学術雑誌)
DOI
10.1038/s41467-022-34078-y

During erythroid differentiation, the maintenance of genome integrity is key for the success of multiple rounds of cell division. However, molecular mechanisms coordinating the expression of DNA repair machinery in erythroid progenitors are poorly understood. Here, we discover that an RNA N6-methyladenosine (m6A) methyltransferase, METTL16, plays an essential role in proper erythropoiesis by safeguarding genome integrity via the control of DNA-repair-related genes. METTL16-deficient erythroblasts exhibit defective differentiation capacity, DNA damage and activation of the apoptotic program. Mechanistically, METTL16 controls m6A deposition at the structured motifs in DNA-repair-related transcripts including Brca2 and Fancm mRNAs, thereby upregulating their expression. Furthermore, a pairwise CRISPRi screen revealed that the MTR4-nuclear RNA exosome complex is involved in the regulation of METTL16 substrate mRNAs in erythroblasts. Collectively, our study uncovers that METTL16 and the MTR4-nuclear RNA exosome act as essential regulatory machinery to maintain genome integrity and erythropoiesis.

リンク情報
DOI
https://doi.org/10.1038/s41467-022-34078-y
PubMed
https://www.ncbi.nlm.nih.gov/pubmed/36307435
ID情報
  • DOI : 10.1038/s41467-022-34078-y
  • PubMed ID : 36307435

エクスポート
BibTeX RIS